Ticker
PRM
Analysis
Proteome Sciences Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PRM.
Proteome Sciences Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PRM.
PRM
Stock
$7.4M
Health Technology
Medical Specialties
GBX
Proteome Sciences Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Proteome Sciences plc has announced a significant new clinical contract related to its target engagement/chemoproteomics platform, which is anticipated to precede a new clinical...
Proteome Sciences plc reported at its Annual General Meeting that its services business is experiencing good order levels and a recovery in TMT and reagent sales in the first ha...
Proteome Sciences plc reported a decrease in total revenues to £3.76 million for the year ended December 31, 2025, down from £4.89 million in 2024, primarily due to a significan...
Vulpes Investment Management Pte Ltd, through its Vulpes Testudo Fund and Vulpes Life Sciences Fund, has increased its stake in Proteome Sciences PLC, crossing a notification th...
Proteome Sciences PLC has successfully completed an oversubscribed Retail Offer, raising £132,000 through the issuance of 7,542,856 shares at 1.75 pence each, with total gross p...
Review valuation context for Proteome Sciences Plc.
Review future growth context for Proteome Sciences Plc.
Review past performance context for Proteome Sciences Plc.
Review financial health context for Proteome Sciences Plc.
Review dividend context for Proteome Sciences Plc.
Review management context for Proteome Sciences Plc.
Review ownership context for Proteome Sciences Plc.
Review other information context for Proteome Sciences Plc.
Review community context for Proteome Sciences Plc.